Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
08/2000
08/17/2000WO2000047235A2 Methods of stimulating angiogenesis
08/17/2000WO2000047234A1 Sustained release salts of pharmaceutically active peptides and their production
08/17/2000WO2000047233A1 Tablets quickly disintegrated in the oral cavity
08/17/2000WO2000047232A1 Sustained release implant, methods for preparation thereof and for treating cancer
08/17/2000WO2000047213A1 Sitostanol formulation with emulsifier to reduce cholesterol absorption and method for preparing and use of same
08/17/2000WO2000047208A1 A transdermal composition of an antivomiting agent and a preparation containing the same
08/17/2000WO2000047203A1 Formulation and system for intra-oral delivery of pharmaceutical agents
08/17/2000WO2000047200A1 Combinations of formoterol and a tiotropium salt
08/17/2000WO2000047192A2 UBIQUINONE QnFOR THE TREATMENT OF PAINS
08/17/2000WO2000047191A1 Laminates containing an active substance for transdermal systems
08/17/2000WO2000047190A2 Method for producing film-type dosage forms
08/17/2000WO2000047189A1 Pharmaceutical effervescent formulation containing metamizol
08/17/2000WO2000047187A1 Serum albumin-based parenteral formulations of polyene macrolides
08/17/2000WO2000047186A1 Polynucleotide compositions for intramuscular and intradermal administration
08/17/2000WO2000047185A1 SPRAY CONTAINING UBIQUINONE Q¿n?
08/17/2000WO2000047184A1 Skin sanitizing compositions
08/17/2000WO2000047183A1 Skin sanitizing compositions
08/17/2000WO2000047179A1 Skin lightening agents
08/17/2000WO2000047166A2 Microemulsion containing alkano lammonium salts of fatty alcohol sulfates and/or alkylpoly alkylene glykol ether sulfates
08/17/2000WO2000047162A1 Improvements in feeder bottles
08/17/2000WO2000047149A1 Gels formed by the interaction of poly(aldehyde) with various substances
08/17/2000WO2000047144A1 Prolonged release bioadhesive vaginal gel dosage form
08/17/2000WO2000047130A1 Injectable collagen-based system for delivery of cells or therapeutic agents
08/17/2000WO2000047062A2 Enteric formulations of proanthocyanidin polymer dietary supplements and methods for preparing same
08/17/2000WO2000047045A1 Preservative compounds and compositions
08/17/2000WO2000032166A3 Microparticles containing water insoluble active agents
08/17/2000WO2000021527A3 Oxaliplatinum preparation packaging
08/17/2000WO2000020602A3 Delta 6 and delta 12 desaturases and modified fatty acid biosynthesis and products produced therefrom
08/17/2000WO2000016752A9 Transdermal devices comprising essential oils for aromatherapy
08/17/2000WO2000007627A3 Topical delivery systems for active agents
08/17/2000DE19956568A1 Verfahren und Medikament zur Hemmung der Expression eines vorgegebenen Gens Method and medicament for the inhibition of expression of a given gene
08/17/2000DE19906368A1 Emulgatoren Emulsifiers
08/17/2000DE19906290A1 Orally administered medicament for treating colon cancer comprises ursodesoxycholic acid in gastric fluid resistant coating to provide direct topical action at target site
08/17/2000DE19906152A1 Wirkstoffhaltige Laminate für Transdermalsysteme Active substance laminates for transdermal
08/17/2000DE19906016A1 Zubereitung für oral zu verabreichende Nahrungsergänzungs- und/oder Arzneimittel in Form von Tabletten Preparation for oral nutritional supplements and / or drug in pill form
08/17/2000DE19905906A1 Flexible, water-soluble or water-dispersible coating agent, binder or film former for pharmaceutical formulations, comprises new or known vinyl ester-polyether graft copolymer,
08/17/2000DE19905880A1 Spray enthaltend Ubichinon Qn Spray containing ubiquinone Q n
08/17/2000DE19905879A1 Ubichinon Qn zur Behandlung von Schmerzen Ubiquinone Q n for the treatment of pain
08/17/2000DE19905801A1 Verfahren zur Herstellung folienförmiger Darreichungsformen Process for producing film-like administration forms
08/17/2000DE19905793A1 Selective release of polymer-encapsulated ingredients, especially drugs, comprises crosslinking the polymer chains with cleavable bridging molecules
08/17/2000DE19905639A1 Wasserlösliche oder wasserquellbare Polymerisate Water-soluble or water-swellable polymers
08/17/2000CA2362662A1 Phosphoramidate, and mono-, di-, and tri-phosphate esters of (1r, cis)-4-(6-amino-9h-purin-9-yl)-2-cyclopentene-1-methanol as antiviral agents
08/17/2000CA2362577A1 Ubiquinone qnfor the treatment of pains
08/17/2000CA2362575A1 Spray containing ubiquinone qn
08/17/2000CA2362561A1 Prolonged release bioadhesive vaginal gel dosage form
08/17/2000CA2361569A1 Injectable collagen-based system for delivery of cells or therapeutic agents
08/17/2000CA2360123A1 Encapsulated cells containing an amplified expression vector as a drug delivery device
08/17/2000CA2359886A1 Polynucleotide compositions for intramuscular and intradermal administration
08/17/2000CA2359706A1 Freeze-dried agent containing paramylon, production and utilization thereof
08/17/2000CA2359674A1 Chain-shortened polynucleotide and method for preparation thereof
08/17/2000CA2298764A1 Pharmaceutical filled hard capsules
08/16/2000EP1028137A2 Polymeric matrices and their uses in pharmaceutical compositions
08/16/2000EP1028129A1 Water-soluble or water-swellable polymers
08/16/2000EP1027921A1 Stable emulsion, method for producing it and the emulsifier
08/16/2000EP1027893A2 Alginate containing medicament and implant for treating fibrosis
08/16/2000EP1027889A2 Ergolin derivates for transdermal application
08/16/2000EP1027888A2 Osmotic system for delivery of solid amorphous dispersions of drugs
08/16/2000EP1027887A2 Matrix controlled release device
08/16/2000EP1027886A2 Pharmaceutical solid dispersions
08/16/2000EP1027885A2 Basic drug compositions with enhanced bioavailability
08/16/2000EP1027413A1 Fractionated vegetable oil
08/16/2000EP1027093A1 Method and apparatus for applying 5-aminolevulinic acid
08/16/2000EP1027085A1 Prepolymer compositions comprising an antimicrobial agent
08/16/2000EP1027072A1 Controlled release compositions comprising gellan gum gels
08/16/2000EP1027071A2 Encapsulated immunomodulators useful as vaccine adjuvants
08/16/2000EP1027065A1 Method for destroying retinal pigment epithelial cells
08/16/2000EP1027062A1 Germicidal compositions for the treatment of animal infectious diseases of the hoof, comprising a copper salt, a quaternary ammonium compound and a peroxide
08/16/2000EP1027057A1 Treatment of female sexual dysfunction
08/16/2000EP1027054A1 Local administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction
08/16/2000EP1027049A1 Intranasal formulation containing scopolamine and method of treating motion sickness
08/16/2000EP1027047A1 Eprosartan arginyl charge-neutralization-complex and a process for its production and formulation
08/16/2000EP1027039A1 Effervescent granules
08/16/2000EP1027038A1 Taste masked pharmaceutical compositions
08/16/2000EP1027037A1 Pharmaceutical preparation comprising clodronate as active ingredient and silicified microcrystalline cellulose as excipient
08/16/2000EP1027036A2 Taste masked formulations
08/16/2000EP1027035A2 Preparation of a lipid blend and a phospholipid suspension containing the lipid blend, and contrast agents based on these
08/16/2000EP1027034A1 Marker for intestinal diagnosis and intestinal therapy
08/16/2000EP1027033A2 High efficiency encapsulation of charged therapeutic agents in lipid vesicles
08/16/2000EP1027029A1 Improved personal care formulations
08/16/2000EP1027015A1 Controlled release of pharmaceuticals in the anterior chamber of the eye
08/16/2000EP1027014A1 Implantable system with drug-eluting cells for on-demand local drug delivery
08/16/2000EP1027011A1 Administration of active agents, including 5-ht receptor agonists and antagonists, to treat premature ejaculation
08/16/2000EP1026947A1 Composition and method for treating penile erectile dysfunction
08/16/2000EP1026945A1 Improved iodine antimicrobial compositions containing nonionic surfactants and halogen anions
08/16/2000EP0912211A4 Medical devices comprising ionically and non-ionically cross-linked polymer hydrogels having improved mechanical properties
08/16/2000EP0831770B1 Continuous fluorochemical microdispersions for the delivery of pharmaceutical agents
08/16/2000EP0812589B1 Combined antipyretic analgesic drug
08/16/2000EP0768896B1 Low-dose steroid tablets containing gallic acid esters as antioxidant agent, process for the manufacture of said tablets, and uses of said tablets
08/16/2000EP0722470B1 Multifunctional organic polymers
08/16/2000EP0707474B1 Medical use of organic aerogels and biodegradable organic aerogels
08/16/2000EP0667166B1 1-alpha,24-(oh)2-vitamin d3 emulsion composition
08/16/2000EP0644929B1 System and method for transplantation of cells
08/16/2000EP0584108B1 Pharmaceutical composition comprising ibuprofen salt
08/16/2000EP0463126B1 Methods of enhancing wound healing and tissue repair
08/16/2000CN1263533A New formulation
08/16/2000CN1263476A A transurethral device
08/16/2000CN1263472A Sustained-release delayed gels
08/16/2000CN1263470A Immunopotentiating composition
08/16/2000CN1263469A Pharmaceutical compositions of peptides having low solubility in physiological medium
08/16/2000CN1263466A Solutions containing azasteroids
1 ... 2458 2459 2460 2461 2462 2463 2464 2465 2466 2467 2468 2469 2470 2471 2472 2473 2474 2475 2476 2477 2478 ... 2991